{"success":true,"data":{"pressRelease":{"id":"59863","rtpr_id":"nACSQVjs1a","ticker":"RGC","exchange":"NASDAQ","all_tickers":["RGC"],"title":"RGC INVESTOR ALERT:  Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit!","author":"ACCESSWIRE","published_at":"2026-06-10T11:00:03.397Z","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / June\n10, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized\ninvestor-rights law firm, announces that a class action lawsuit has been filed\nagainst Regencell Bioscience Holdings Ltd. (NASDAQ:RGC) and certain of its\nofficers.\n(https://app.accessnewswire.com/imagelibrary/a4b7feb7-9f91-4035-b70f-be4293b70fe9/bronstein-gewirtz-and-grossman-llc.png)\nThis lawsuit seeks to recover damages against Defendants for alleged\nviolations of the federal securities laws on behalf of all persons and\nentities that purchased or otherwise acquired Regencell securities between\nOctober 28, 2024 and October 31, 2025, both dates inclusive (the \"Class\nPeriod\"). Such investors are encouraged to join this case by visiting the\nfirm's site: bgandg.com/RGC.\n(https://bgandg.com/RGC/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=RGC)\n\nRegencell Case Details\n\nThe complaint alleges that throughout the Class Period, Defendants made\nmaterially false and misleading statements regarding the Company's business,\noperations, and compliance policies. Specifically, the Complaint alleges that\nDefendants made false and/or misleading statements and/or failed to disclose\nthat:\n\n(1) Regencell was vulnerable and/or subject to market manipulation;\n\n(2) the resulting volatility in the market for the Company's ordinary shares\nexposed Regencell's investors to significant financial risk;\n\n(3) all the foregoing subjected Regencell to a heightened risk of regulatory\nand/or governmental scrutiny and enforcement action, as well as significant\nlegal, monetary, and reputational harm; and\n\n(4) as a result, Defendants' public statements were materially false and\nmisleading at all relevant times.\n\nWhat's Next for Regencell Investors?\n\nA class action lawsuit has already been filed. If you wish to review a copy of\nthe Complaint, you can visit the firm's site: bgandg.com/RGC.\n(https://bgandg.com/RGC/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=RGC)\nor you may contact Peretz Bronstein, Esq. or his Client Relations Manager,\nNathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911\n(tel:+9175900911). If you suffered a loss in Regencell you have until June 23,\n2026, to request that the Court appoint you as lead plaintiff. Your ability to\nshare in any recovery doesn't require that you serve as lead plaintiff.\n\nNo Cost to Regencell Investors\n\nWe, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on\na contingency fee basis. That means we will ask the court to reimburse us for\nout-of-pocket expenses and attorneys' fees, usually a percentage of the total\nrecovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for Regencell Securities Class Action?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide. More at www.bgandg.com\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/rgc-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1161396)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACSQVjs1a","title":"RGC INVESTOR ALERT:  Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit!","author":"ACCESSWIRE","ticker":"RGC","created":"2026-06-10T11:00:03.397Z","tickers":["RGC"],"exchange":"NASDAQ","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / June\n10, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized\ninvestor-rights law firm, announces that a class action lawsuit has been filed\nagainst Regencell Bioscience Holdings Ltd. (NASDAQ:RGC) and certain of its\nofficers.\n(https://app.accessnewswire.com/imagelibrary/a4b7feb7-9f91-4035-b70f-be4293b70fe9/bronstein-gewirtz-and-grossman-llc.png)\nThis lawsuit seeks to recover damages against Defendants for alleged\nviolations of the federal securities laws on behalf of all persons and\nentities that purchased or otherwise acquired Regencell securities between\nOctober 28, 2024 and October 31, 2025, both dates inclusive (the \"Class\nPeriod\"). Such investors are encouraged to join this case by visiting the\nfirm's site: bgandg.com/RGC.\n(https://bgandg.com/RGC/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=RGC)\n\nRegencell Case Details\n\nThe complaint alleges that throughout the Class Period, Defendants made\nmaterially false and misleading statements regarding the Company's business,\noperations, and compliance policies. Specifically, the Complaint alleges that\nDefendants made false and/or misleading statements and/or failed to disclose\nthat:\n\n(1) Regencell was vulnerable and/or subject to market manipulation;\n\n(2) the resulting volatility in the market for the Company's ordinary shares\nexposed Regencell's investors to significant financial risk;\n\n(3) all the foregoing subjected Regencell to a heightened risk of regulatory\nand/or governmental scrutiny and enforcement action, as well as significant\nlegal, monetary, and reputational harm; and\n\n(4) as a result, Defendants' public statements were materially false and\nmisleading at all relevant times.\n\nWhat's Next for Regencell Investors?\n\nA class action lawsuit has already been filed. If you wish to review a copy of\nthe Complaint, you can visit the firm's site: bgandg.com/RGC.\n(https://bgandg.com/RGC/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=RGC)\nor you may contact Peretz Bronstein, Esq. or his Client Relations Manager,\nNathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911\n(tel:+9175900911). If you suffered a loss in Regencell you have until June 23,\n2026, to request that the Court appoint you as lead plaintiff. Your ability to\nshare in any recovery doesn't require that you serve as lead plaintiff.\n\nNo Cost to Regencell Investors\n\nWe, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on\na contingency fee basis. That means we will ask the court to reimburse us for\nout-of-pocket expenses and attorneys' fees, usually a percentage of the total\nrecovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for Regencell Securities Class Action?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide. More at www.bgandg.com\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/rgc-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1161396)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-06-10T11:00:03.539080479Z","server_sent_at_ms":1781089203539},"received_at":"2026-06-10T11:00:03.593Z","source_url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/rgc-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1161396"},"analysis":{"id":"49290","press_release_id":"59863","analysis_json":{"redFlags":[],"eventType":"legal_litigation","narrative":"Bronstein, Gewirtz & Grossman, LLC issued a shareholder-solicitation notice naming Regencell Bioscience Holdings Ltd. (RGC); no new disclosure from the company itself.\n\nThe release is a routine lead-plaintiff-deadline reminder soliciting investors with losses to contact the firm on a contingency basis.\n\nThis is law-firm marketing, not an issuer disclosure or a court action; treat as low-signal noise.","sentiment":"neutral","keyFigures":{},"quotedText":"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace","namedEntities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"Regencell Bioscience Holdings Ltd.","ticker":"RGC"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Bronstein, Gewirtz & Grossman, LLC. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"RGC"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Bronstein, Gewirtz & Grossman, LLC issued a shareholder-solicitation notice naming Regencell Bioscience Holdings Ltd. (RGC); no new disclosure from the company itself.\n\nThe release is a routine lead-plaintiff-deadline reminder soliciting investors with losses to contact the firm on a contingency basis.\n\nThis is law-firm marketing, not an issuer disclosure or a court action; treat as low-signal noise.","key_figures":{},"named_entities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"Regencell Bioscience Holdings Ltd.","ticker":"RGC"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-06-10T11:08:47.969Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":33435,"modelName":"george-droid-qwen-72b"}}